GoodRx vs Zealthy
GoodRx costs $137 less a month, and both sell tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Zealthy
Best for: coaching bundled into the price rather than sold separately
Visit Zealthy →If you are choosing between GoodRx and Zealthy, the first difference is cost: GoodRx is $137 a month cheaper at the entry price. Both prescribe tirzepatide, so moving from one to the other would not change your drug. GoodRx leads our six-part score, 6.9 to 5.4. One of the two has an FDA warning letter on record, covered below.
GoodRx vs Zealthy price
GoodRx is the cheaper way in: $149 a month against $286 a month at Zealthy. That is $137 less each month (48% lower), or about $1,644 over a year of treatment.
Drug by drug: Tirzepatide is cheaper at GoodRx ($299 a month vs $351 a month).
Medications and formats
Both sell tirzepatide; only GoodRx lists orforglipron; only Zealthy lists semaglutide.
On format, GoodRx prices brand-name pens, while Zealthy prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Zealthy lists 34 states.
They overlap in 34 states. GoodRx alone covers 16 states, including Alaska, Delaware, Hawaii and Montana.
Pricing
GoodRx
Zealthy
$151 medication + $135 monthly membership
$216 medication + $135 monthly membership
What each price covers
Zealthy's price also covers the clinician visit, shipping and coaching, which GoodRx does not claim.
GoodRx does not say what its price includes.
Zealthy is silent on the medication itself and lab work.
GoodRx
Inclusions not disclosed.
Zealthy
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, GoodRx scores 6.9 and Zealthy 5.4 out of 10.
GoodRx is stronger on value (5.0 vs 3.0), user experience (5.0 vs 3.0), trust & safety (6.0 vs 3.0) and accessibility (10.0 vs 7.4).
Zealthy is stronger on support (5.5 vs 5.0).
Effectiveness is within half a point.
GoodRx
6.9/10
Zealthy
5.4/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Zealthy has 2 FDA warning letters on record.
GoodRx has no FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Zealthy |
|---|---|---|
| Starting Price | ✓$149/mo | $286/mo |
| Features | ✓6 features | 3 features |
| States Available | ✓50 | 34 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 2 letters |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Zealthy
Active federal litigation and two FDA warning letters are disclosed in full; the entry exists here only for completeness, and the warnings and cons sections should be read before considering it. Zealthy sells compounded semaglutide and tirzepatide on an asynchronous telehealth model. FitRX, LLC is the legal entity, recently renamed Gronk Inc.
Read our full Zealthy review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Zealthy
What we like
- The monthly price includes clinician visits, shipping and coaching
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Serves only 34 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Zealthy 2 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 5.4, above all for oral orforglipron alongside the injectables. It also costs $137 less each month than Zealthy. Zealthy fits better if coaching bundled into the price rather than sold separately is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Zealthy if…
You want coaching bundled into the price rather than sold separately and an opening price near $286 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →GoodRx vs Zealthy: FAQ
Close alternatives to GoodRx and Zealthy
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Zealthy vs Aspen
- Zealthy vs Joey Med
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.